Search Results - "Schoser, B. G."
-
1
Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited
Published in Neuropathology and applied neurobiology (01-10-2007)“…The need for clinical awareness and diagnostic precision of glycogen storage disease type 2 (GSD2) has increased, as enzyme replacement therapy has become…”
Get full text
Journal Article -
2
Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers
Published in Acta neurologica Scandinavica (01-04-2002)“…Objectives– To further examine the role of proteolytic enzyme expression of matrix metalloproteinases (MMP) and T‐cell markers in inflammatory myopathies and…”
Get full text
Journal Article -
3
Serum levels of matrix metalloproteinases-2 and -9 and their tissue inhibitors in inflammatory neuromuscular disorders
Published in European neurology (01-08-2006)“…We monitored serum levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) before and during intravenously applied immunoglobulin (IVIG)…”
Get more information
Journal Article -
4
Molecular biomarkers monitoring human skeletal muscle fibres and microvasculature following long‐term bed rest with and without countermeasures
Published in Journal of anatomy (01-03-2008)“…The cellular mechanisms of human skeletal muscle adaptation to disuse are largely unknown. The aim of this study was to determine the morphological and…”
Get full text
Journal Article -
5
Matrix metalloproteinases MMP-2, MMP-7 and MMP-9 in denervated human muscle
Published in Neuroreport (09-09-1999)“…PROTEOLYTIC enzyme expression was studied by matrix metalloproteinases (MMP) immunoreactivity (-IR) in muscle biopsies from patients with amyotrophic lateral…”
Get full text
Journal Article -
6
Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P
Published in Brain (London, England : 1878) (01-06-2007)“…In 1965, an adult-onset, autosomal dominant disorder with a peculiar scapuloperoneal distribution of weakness and atrophy was described in a large,…”
Get full text
Journal Article -
7
Coenzyme Q10 deficiency and isolated myopathy
Published in Neurology (24-01-2006)“…Three unrelated, sporadic patients with muscle coenzyme Q10 (CoQ10) deficiency presented at 32, 29, and 6 years of age with proximal muscle weakness and…”
Get full text
Journal Article -
8
Sudden cardiac death in myotonic dystrophy type 2
Published in Neurology (28-12-2004)“…Medical records and follow-up data were reviewed in 297 genetically proven myotonic dystrophy type 2 (DM2) patients. Patients were selected by the criteria of…”
Get full text
Journal Article -
9
Autoimmune hyperthyroidism in multiple sclerosis under treatment with glatiramer acetate - a case report
Published in European journal of neurology (01-03-2001)Get full text
Journal Article -
10
-
11
Cerebral hyperperfusion injury after percutaneous transluminal angioplasty of extracranial arteries
Published in Journal of neurology (16-01-1997)Get full text
Journal Article -
12
A tRNA(Ala) mutation causing mitochondrial myopathy clinically resembling myotonic dystrophy
Published in Journal of medical genetics (01-10-2003)Get full text
Journal Article -
13
Outcome and effect of pregnancy in myotonic dystrophy type 2
Published in Neurology (28-02-2006)“…The authors reviewed the obstetric histories of 42 women of 37 families with myotonic dystrophy type 2 (DM2). Nine women (21%) had the first symptoms during…”
Get full text
Journal Article -
14
McLeod myopathy revisited: more neurogenic and less benign
Published in Brain (London, England : 1878) (01-12-2007)“…The X-linked McLeod neuroacanthocytosis syndrome (MLS) has originally been denoted as ‘benign’ McLeod myopathy. We assessed the clinical findings and the…”
Get full text
Journal Article -
15
CD95-mediated apoptosis and DNA fragmentation in MS
Published in Acta neurologica Scandinavica (01-11-2000)“…Objective– To investigate possible associations of soluble CD95 (sCD95) serum levels and DNA defragmentation with different MS disease stages and activities…”
Get full text
Journal Article -
16
Mutations in the acid α-glucosidase gene (M. Pompe) in a patient with an unusual phenotype
Published in Neurology (25-01-2005)“…Glycogenosis type II (Pompe disease) is a lysosomal storage disease caused by deficiency of acid alpha-glucosidase (acid maltase). The disease is autosomal…”
Get full text
Journal Article -
17
A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation
Published in Neurology (26-12-2001)“…To determine the cause of sporadic rippling muscle disease (RMD) in a 24-year-old patient. RMD is a rare myopathy characterized by percussion-induced rapid…”
Get full text
Journal Article -
18
The impact of raised intracranial pressure on cerebral venous hemodynamics : a prospective venous transcranial Doppler ultrasonography study
Published in Journal of neurosurgery (01-11-1999)“…The effect of increased intracranial pressure (ICP) on cerebral venous blood flow has been the subject of very few clinical and experimental studies. The…”
Get full text
Journal Article -
19
Brain imaging and neuropsychology in late-onset dementia due to a novel mutation (R93C) of valosin-containing protein
Published in Clinical neuropathology (01-09-2007)“…Inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD, MIM 167320) is a recently identified autosomal dominant disorder due to…”
Get more information
Journal Article -
20
Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease
Published in Journal of neurology, neurosurgery and psychiatry (01-09-2004)“…Rippling muscle disease (RMD) is a rare muscle disorder characterised by muscle stiffness, exercise induced myalgia, and cramp-like sensations. It is…”
Get full text
Journal Article